Formerly known as HWG Minerals Sdn Bhd, HWG Capital Sdn Bhd is a wholly-owned subsidiary under the HWGB Group that focuses on the Group’s investment projects. It is driven by an established team of advisors who spur the company to greater financial success.
In August 2020, HWG Capital Sdn Bhd made its first investment via another HWGB subsidiary, HWGB Biotech Sdn Bhd; where it has invested US$1 million with E-MO Biology Inc (EBI) for the research and development of vaccines, immunological treatment and diagnostic product development in relation to the COVID-19 virus. This sets HWG Capital Sdn Bhd up in identifying potential investment opportunities in future projects with great prospects.